nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Chagas disease and stroke
|
Carod-Artal, Francisco Javier |
|
2010 |
9 |
5 |
p. 533-542 10 p. |
artikel |
2 |
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial
|
Wong, Ka Sing Lawrence |
|
2010 |
9 |
5 |
p. 489-497 9 p. |
artikel |
3 |
Disaster relief in Haiti: a perspective from the neurologists on the USNS COMFORT
|
Etienne, Mill |
|
2010 |
9 |
5 |
p. 461-463 3 p. |
artikel |
4 |
Does mitochondrial DNA have a protective role in stroke?
|
Meschia, James F |
|
2010 |
9 |
5 |
p. 453-454 2 p. |
artikel |
5 |
Early prognosis in traumatic brain injury: from prophecies to predictions
|
Lingsma, Hester F |
|
2010 |
9 |
5 |
p. 543-554 12 p. |
artikel |
6 |
Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke
|
Rothwell, Peter M |
|
2010 |
9 |
5 |
p. 469-480 12 p. |
artikel |
7 |
Erratum
|
|
|
2010 |
9 |
5 |
p. 463- 1 p. |
artikel |
8 |
February, 2010
|
|
|
2010 |
9 |
5 |
p. 467- 1 p. |
artikel |
9 |
Francisco Javier Carod-Artal: from Aragón to the Amazon
|
Burton, Adrian |
|
2010 |
9 |
5 |
p. 466- 1 p. |
artikel |
10 |
Lithium time-to-event trial in amyotrophic lateral sclerosis stops early for futility
|
Swash, Michael |
|
2010 |
9 |
5 |
p. 449-451 3 p. |
artikel |
11 |
Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study
|
Chinnery, Patrick F |
|
2010 |
9 |
5 |
p. 498-503 6 p. |
artikel |
12 |
Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage
|
Rabinstein, Alejandro A |
|
2010 |
9 |
5 |
p. 504-519 16 p. |
artikel |
13 |
Neurological burden of acute rheumatic fever and rheumatic heart disease: the case for action
|
The Lancet Neurology, |
|
2010 |
9 |
5 |
p. 447- 1 p. |
artikel |
14 |
News in brief
|
|
|
2010 |
9 |
5 |
p. 468- 1 p. |
artikel |
15 |
Oral therapies for multiple sclerosis: are we there yet?
|
Hartung, Hans-Peter |
|
2010 |
9 |
5 |
p. 454-457 4 p. |
artikel |
16 |
Reducing blood pressure variability to prevent stroke?
|
Gorelick, Philip B |
|
2010 |
9 |
5 |
p. 448-449 2 p. |
artikel |
17 |
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
|
Aggarwal, Swati P |
|
2010 |
9 |
5 |
p. 481-488 8 p. |
artikel |
18 |
Swati Aggarwal
|
|
|
2010 |
9 |
5 |
p. 467- 1 p. |
artikel |
19 |
The changing demographic pattern of multiple sclerosis epidemiology
|
Koch-Henriksen, Nils |
|
2010 |
9 |
5 |
p. 520-532 13 p. |
artikel |
20 |
Time matters for reducing risk of stroke
|
Kaste, Markku |
|
2010 |
9 |
5 |
p. 451-453 3 p. |
artikel |
21 |
Towards a modern classification of the epilepsies?
|
Berg, Anne T |
|
2010 |
9 |
5 |
p. 459-461 3 p. |
artikel |
22 |
Venous abnormalities and multiple sclerosis: another breakthrough claim?
|
Qiu, Jane |
|
2010 |
9 |
5 |
p. 464-465 2 p. |
artikel |
23 |
When the past challenges the present: are older antiepileptic drugs still the best choice in childhood absence epilepsy?
|
Arzimanoglou, Alexis |
|
2010 |
9 |
5 |
p. 457-459 3 p. |
artikel |